Self Assessment of Buccodental Toxicity - Comparison of Patients With Metastatic Renal-cell Carcinoma (RCC) Treated With Sunitinib to Patients Treated With Chemotherapy

被引：0
|
作者：
Gilabert, M. [1 ]
Provansal, M. [1 ]
Cappiello, M. [1 ]
Walz, J. [1 ]
Brunelle, S. [1 ]
Salem, N. [1 ]
Gravis, G. [1 ]
机构：
[1] Inst J Paoli I Calmettes, F-13009 Marseille, France
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72060-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S518 / S518
页数：1
相关论文
共 50 条
  • [41] Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiency
    Kim, Ki Hyang
    Kim, Ho Young
    Kim, Hye Ryun
    Sun, Jong-Mu
    Lim, Ho Yeong
    Lee, Hyo Jin
    Lee, Suee
    Bae, Woo Kyun
    Rha, Sun Young
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (04) : 746 - 752
  • [42] PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH CHEMOTHERAPY
    Davidov, Deyan
    JOURNAL OF IMAB, 2016, 22 (01): : 1045 - 1049
  • [43] Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
    Schmidinger, Manuela
    Zielinski, Christoph C.
    Vogl, Ursula M.
    Bojic, Andja
    Bojic, Marija
    Schukro, Christoph
    Ruhsam, Marquerite
    Hejna, Michael
    Schmidinger, Herwig
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (32) : 5204 - 5212
  • [44] Management of Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib and Clinical Outcomes
    Arakawa-Todo, Maki
    Yoshizawa, Takahiko
    Zennami, Kenji
    Nishikawa, Genya
    Kato, Yoshiharu
    Kobayashi, Ikuo
    Kajikawa, Keishi
    Yamada, Yoshiaki
    Matsuura, Katsuhiko
    Tsukiyama, Ikuto
    Saito, Hiroko
    Hasegawa, Takaaki
    Nakamura, Kogenta
    Sumitomo, Makoto
    ANTICANCER RESEARCH, 2013, 33 (11) : 5043 - 5050
  • [45] Re: Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib Response
    Rini, Brian I.
    Cohen, Darrel P.
    Lu, Dongrui R.
    Chen, Isan
    Hariharan, Subramanian
    Gore, Martin E.
    Figlin, Robert A.
    Baum, Michael S.
    Motzer, Robert J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (20):
  • [46] Re: Clinical Outcomes for Patients with Metastatic Renal Cell Carcinoma Treated with Alternative Sunitinib Schedules
    Zigeuner, Richard
    EUROPEAN UROLOGY, 2014, 66 (04) : 785 - 785
  • [47] Outcome of Patients With Renal Cell Carcinoma Metastatic to the Brain Treated With Sunitinib Without Local Therapy
    Lim, Zita Dubauskas
    Mahajan, Anita
    Weinberg, Jeffrey
    Tannir, Nizar M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (03): : 258 - 260
  • [48] Body Composition by Computed Tomography as a Predictor of Toxicity in Patients With Renal Cell Carcinoma Treated With Sunitinib
    Cushen, Samantha J.
    Power, Derek G.
    Teo, Min Y.
    MacEneaney, Peter
    Maher, Michael M.
    McDermott, Ray
    O'Sullivan, Kathleen
    Ryan, Aoife M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (01): : 47 - 52
  • [49] Retrospective study assessing the association of single nucleotide polymorphisms in VEGFR3 and on-target toxicity in patients with advanced renal-cell carcinoma (RCC) treated with sunitinib.
    Rodriguez-Moreno, Jf.
    Esteban, Emilio
    Javier Leandro-Garcia, Luis
    Castellano, Daniel E.
    Gonzalez del Alba, Aranzazu
    Angel Climent, Miguel
    Angel Arranz, Jose
    Gallardo, Enrique
    Puente, Javier
    Bellmunt, Joaquim
    Mellado, Begona
    Martinez, Esther
    Moreno, Fernando
    Font, Albert
    Robledo, Mercedes
    Hernando Polo, Susana
    Garcia-Donas, Jesus
    Rodriguez-Antona, Cristina
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [50] Pazopanib or sunitinib for metastatic renal-cell carcinoma?
    Bennet, Neil
    LANCET ONCOLOGY, 2013, 14 (11): : E442 - E442
12345